ProCE Banner Activity

Slides on Key Decisions in HIV Care: Considerations for Long-Acting Injectable PrEP

Slideset Download
Learn some of the key considerations for using long-acting injectable cabotegravir for PrEP including management of missed dosing, stopping PrEP, and screening for HIV while on PrEP.

Released: March 15, 2022

Expiration: March 14, 2023

No longer available for credit.

Share

Faculty

Jason Schafer

Jason Schafer, PharmD, MPH

Professor and Vice Chair
Jefferson College of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Jason Schafer, PharmD, MPH

Professor and Vice Chair
Jefferson College of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania

Jason Schafer, MD, MPH, has disclosed that he has received funds for research support from Gilead Sciences and Merck and consulting fees from Merck and ViiV.